Concepedia

Anshu Joshi

AJ

Statistics

Publications

14

Citations

3K

H-Index

12

Active since

2019

Affiliations

University of Washington(Current)

Vir Biotechnology (Switzerland)

Howard Hughes Medical Institute

VIR Biotechnology (United States)

Fred Hutch Cancer Center

Anshu Joshi is an author at University of Washington specializing in infectious diseases, immunology, and molecular virology.

Publications per year

2019–2025

14

Publications

14

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Bo Meng, Adam Abdullahi, Isabella A.T.M. Ferreira et al. · Nature · 2022 · 1.2K citations · Full text

, , +17

Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement

Matthew McCallum, Nadine Czudnochowski, Laura E. Rosen et al. · Science · 2022 · 572 citations · Full text

, , +17

Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies

Florian A. Lempp, Leah Soriaga, Martin Montiel-Ruiz et al. · Nature · 2021 · 326 citations · Full text

, , +14

SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses

Alexandra C. Walls, Kaitlin R. Sprouse, John E. Bowen et al. · Cell · 2022 · 222 citations · Full text

, , +17

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies

Jun Siong Low, Josipa Jerak, M. Alejandra Tortorici et al. · Science · 2022 · 186 citations

, , +17

1–5 of 14